Dr. Deborah Marshall


Professor, Cumming School of Medicine, Departments of Community Health Sciences and Medicine

Arthur J.E. Child Chair Rheumatology Outcomes Research

Canada Research Chair Tier 2, Health Systems and Services Research (2008-2018)


Biography

Dr. Deborah A Marshall is the Arthur J.E. Child Chair of Rheumatology Outcomes Research and former Canada Research Chair, Health Services and Systems Research (2008-2018). In addition, she is a member of the McCaig Institute of Bone and Joint Health, O’Brien Institute of Public Health, Alberta Children’s Hospital Research institute (ACHRI), and a Senior Scientist at Arthritis Research Canada.

Dr Marshall’s research programme is focused on assessing the value of health care interventions through measurement of patient preferences, cost-effectiveness analysis, and simulation modeling of health care delivery systems in the context of precision medicine and patient engagement and patient centeredness. She is a founding co-investigator of the innovative Patient and Community Engagement Research (PaCER) Program at the University of Calgary which trains patients to design and conduct health research, using specific adapted methods of qualitative inquiry. She has experience in technology assessment agencies, academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe.

Dr Marshall co-leads the health economics, patient preferences and patient engagement activities for 3 large national and international research programmes in precision medicine: 1) UCAN CAN DU (Canada-Netherlands personalized medicine network in childhood arthritis and rheumatic disease, CIHR/Genome Canada); 2) UCAN CURE (Precision Decisions for Childhood Arthritis, CIHR/Genome Canada); 3) SOLVE (Care4Rare Canada: Harnessing multi-omics to deliver innovative diagnostic care for rare genetic diseases in Canada). Dr. Marshall is also the co-lead of the Patient Engagement theme for IMAGINE (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects) – a CIHR Strategy for Patient Oriented Research (SPOR) Chronic Disease Network.

Biography continued

Dr. Marshall is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Past President of the Board of Directors, the Chair of the Dynamic Simulation Modeling Applications in Health Care Delivery Research Task Force and as a member of the Patient Preferences Special Interest Group, the Optimization Methods Task Force and co-author of related ISPOR Task Force Reports.   She has also served as a member of the Board of Directors for Health Technology Assessment International (HTAi). She is the former co-chair of the Scientific Research Committee and member of the Board of Directors of the Arthritis Alliance of Canada (AAC), and a member of the Scientific Advisory Committee of the Alberta PROMs & EQ-5D Research & Support Unit (APERSU).

Education and Training

Ph.D., School of Public Health, University of North Carolina; M.H.S.A, University of Alberta; BSc(Hons) University of Toronto

Research Interests and Expertise

  • Patient preferences using stated preferences methods in health care applications.
  • Care pathway and health system modeling using dynamic simulation modeling as a health services planning tool.
  • Economic evaluation of health care programmes using decision analysis and simulation methods, particularly cost effectiveness of testing and treatment interventions in personalised medicine.
  • Tools to inform personalized decision making in health

Contact

damarsha@ucalgary.ca

Marshall